Search Results 6901-6910 of 34551 for oral

  1. Chemical splash in the eye: First aid - Mayo Clinic

    Chemicals may be in liquid or powdered form and can cause irritation and burns. The most dangerous chemicals are strong acids or alkali. Alkali burns tend to be ...

  2. Development of a Peptide-Based SARS-CoV-2 Candidate Vaccine - Mayo Clinic

    Receipt of oral prednisone or other immunosuppressive medications within 30 days prior to the study blood draw (inhaled, intranasal, or intra-articular ...

  3. Dyslexia - Diagnosis and treatment - Mayo Clinic

    This learning disorder involves difficulty reading due to problems identifying speech sounds and learning how they relate to letters and words.

  4. VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial Cancer - Mayo Clinic

    Treatment with oral/systemic corticosteroids, with the exception of topical or inhaled steroids. Exposure to household contacts ≤15 months old or household ...

  5. A Study of the Safety and Drug/Body Interactions of LAM-002A for Patients with Non-Hodgkin's Lymphoma - Mayo Clinic

    Able to swallow oral capsules without difficulty; Using acceptable birth control; Women of childbearing potential must have a negative serum or urine ...

  6. A Study of Niraparib Combined with Pembrolizumab (MK-3475) in Patients who have Triple-Negative Breast Cancer or Ovarian Cancer - Mayo Clinic

    Able to take oral medications; Female patient, if of childbearing potential, has a negative serum pregnancy test within 72 hours of taking study medication ...

  7. ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection - Mayo Clinic

    About this study. Subjects will receive an oral dose of SER-109 in 4 capsules once daily for 3 consecutive days in Treatment Group I or matching placebo ...

  8. Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery - Mayo Clinic

    ... oral cavity, or cervix are all permissible); No severe, active co-morbidity, defined as follows: Unstable angina and/or congestive heart failure requiring ...

  9. A Clinical Trial To Evaluate The HeartWare Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL) - Mayo Clinic

    Female patients of childbearing potential must agree to use adequate contraceptive precautions (defined as oral contraceptives, intrauterine devices ...

  10. A Study To Evaluate Efficacy And Safety Of Deucravacitinib In Participants With Active Discoid And/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) - Mayo Clinic

    Currently receiving treatment for DLE/SCLE with a stable regimen of at least one of the following medications: oral corticosteroid, and/or antimalarial, and/or ...